Biography
Essam Ghanem is an experienced physician and European Qualified Person for Pharmacovigilance (EUQPPV). Having almost 28 years of experience in clinical research and drug development in academic institutes, Pharmaceutical Industry and Contractual Research Organisations. Essam Ghanem is the head of pharmacovigilance and Chief Medical officer at the consultation company “VIGI-CARE.BVBA†that offers a comprehensive range of pharmacovigilance services.
Research Interest
Pharmacovigilance and Drug Safety
Biography
Dr. Jamal Golbahar is an Associate Professor of Clinical Biochemistry and Molecular Medicine, founder and director of Dr Golbahar Newborn Screening Laboratory in Shiraz, South West of Iran. As a member of International Society of Neonatal Screening Dr. Golbahar has been actively involved in molecular medicine field and promoting and advocating the newborn screening and genetic testing in the Middle East for over 18 years. He has also been actively involved in providing reviews and expert advice to newborn screening programs and genetic testing in the Middle East. Dr Golbahar earned a bachelor’s degree in Biomedical Sciences from Bradford University, UK, and master’s and doctorate degrees in Clinical Biochemistry from Leeds University, UK. He is a UK certified Pediatric Clinical Biochemist and his research interests in molecular medicine include; inborn errors of metabolism and he has been principal investigator on a number of clinical studies exploring Gene-nutrients interaction and has also pursued clinical research studies relating to the inherited metabolic disorders with more than 25 publications.
Research Interest
Genetics, Clinical Biochemistry
Biography
Dr. Alaa Bagalagel, Pharm.D., CDE, is assistant professor of clinical pharmacy at the Faculty of Pharmacy, King Abdulaziz University. Dr. Bagalagel is the director of pharmaceutical training unit. Dr. Bagalagel earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Ambulatory Care Specialty Residency training at The University of Arizona.Dr. Bagalagel completed a Postdoctoral Fellowship at The University of Arizona. Dr. Bagalagel is Certified Diabetes Educator. He provides a service as Ambulatory care consultant at King Abdulaziz University Hospital. He is an active member of the biosimilar working group at The University of Arizona Health Outcomes and PharmacoEconomic Center.
Research Interest
His area of research includes: clinical safety and efficacy of biosimilars, diabetes care, and drug reactions.